The network pharmacology analysis showed that quercetin is involved in mediating cancer-related pathways, PI3K-Akt pathway, and Ras pathway to interfere with IPF by acting on AKT1 and PIK3CG (Zhang et al., 2021). The gene discussed is PIK3CG; the disease is idiopathic pulmonary fibrosis.